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Allergic diseases mediated by T helper type (Th) 2 cell immune responses are rising dramatically 
in most developed countries. Exaggerated Th2 cell reactivity could result, for example, from 
diminished exposure to Th1 cell–inducing microbial infections. Epidemiological studies, however, 
indicate that Th2 cell–stimulating helminth parasites may also counteract allergies, possibly 
by generating regulatory T cells which suppress both Th1 and Th2 arms of immunity. We 
therefore tested the ability of the Th2 cell–inducing gastrointestinal nematode 
 
Heligmosomoides 
polygyrus
 
 to influence experimentally induced airway allergy to ovalbumin and the house 
dust mite allergen Der p 1. Inflammatory cell infiltrates in the lung were suppressed in 
infected mice compared with uninfected controls. Suppression was reversed in mice treated 
with antibodies to CD25. Most notably, suppression was transferable with mesenteric lymph 
node cells (MLNC) from infected animals to uninfected sensitized mice, demonstrating that 
the effector phase was targeted. MLNC from infected animals contained elevated numbers of 
CD4
 
 
 
CD25
 
 
 
Foxp3
 
 
 
 T cells, higher TGF-
 
 
 
 expression, and produced strong interleukin (IL)-10 
responses to parasite antigen. However, MLNC from IL-10–deficient animals transferred 
suppression to sensitized hosts, indicating that IL-10 is not the primary modulator of the 
allergic response. Suppression was associated with CD4
 
 
 
 T cells from MLNC, with the 
CD4
 
 
 
CD25
 
 
 
 marker defining the most active population. These data support the contention 
that helminth infections elicit a regulatory T cell population able to down-regulate allergen 
induced lung pathology in vivo.
INTRODUCTION
 
The prevalence of allergic diseases, such as
asthma and allergic rhinitis, continues to rise in
developed countries (1–4). Asthma is a multi-
farious polygenic disease, in which allergens
elicit early- and late-phase airway inflammatory
responses culminating in broncho-constriction
and airway remodeling. However, sensitization
to allergens and disease manifestation is pliant
to environmental influences (5–9).
Allergies have traditionally been considered
to be Th2 cell–derived immunopathologies, and
earlier thinking suggested that declining micro-
bial exposure in Western populations resulted
in a weaker Th1 cell responsiveness, and a pro-
pensity to develop Th2 cell responses to innocu-
ous allergens (10). However, it is increasingly
clear that an imbalance between immunoregu-
latory and Th2 effector mechanisms can mod-
ulate allergy in a critical fashion (2, 3, 11–15).
This conclusion has been supported by studies
of Th2 cell–inducing human helminth infec-
tions, in which both observational and post-
therapy data show an inverse association between
chronic infection and overt allergic responsive-
ness (16, 17). Interestingly, infection primarily
regulates late-stage effector phase mechanisms,
as proallergic IgE responses remain intact in
infected patients (18–23).
Evidence for immune suppression during
helminth infections is strong (24–27), and recent
studies identified inhibitory mechanisms that
dampen allergic and/or autoimmune pathologies
(28, 29). Further data now support a role for
regulatory T cells (T reg cells) in helminth infec-
tion. In human studies, peripheral T cells from
infected patients are nonresponsive to parasite
antigens, but responses can be restored by anti-
bodies to IL-10 and TGF-
 
 
 
 (26). Moreover, T
cell clones from 
 
Onchocerca volvulus
 
–infected
patients show antigen-specific IL-10 production
and release of TGF-
 
 
 
 characteristic of T reg
cells (25, 30). Our most recent studies have
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demonstrated the expansion of regulatory phenotype T cells
in the mouse model filarial infection 
 
Litomosoides sigmodontis
 
,
and the killing of parasites in animals given antibodies to T
reg cell surface marker proteins (31).
New approaches to allergy intervention has focused on
restoring regulation. Notably, there is a case building for T
reg cells controlling allergic airway inflammation (13, 15,
32–35). For example, T cells that were transfected with IL-
10 or TGF-
 
 
 
 to confer regulatory function (36, 37) prevent
allergic airway inflammation (38). Therefore, the emergence
of pathogen-induced T cell regulation together with new
concepts of allergy control by T cells provides a feasible
model for helminth suppression of allergy.
The data from human studies provide an enticing sce-
nario in which helminth infections keep allergies at bay, but
such epidemiological inferences must be tested experimen-
tally if we are to distinguish cause from consequence in these
complex immunological settings. Here, we investigate the
host immune response at the convergence of these two im-
munological challenges, which as we show, interact in a dra-
matic manner. We test allergic airway inflammation, in-
duced by either OVA in the BALB/c strain of mouse or Der
p 1 in the C57BL/6 mouse, in mice infected with the intes-
tinal nematode 
 
Heligmosomoides polygyrus
 
 that elicits a
strongly Th2 cell–biased systemic response (39, 40). This
parasite has been reported to down-regulate allergies to di-
etary antigens (28), as well as other intestinal pathologies (41,
42). By studying airway allergy in our experiments, we can
exploit the fact that 
 
H. polygyrus
 
 remains entirely within the
gastrointestinal tract, and test the immunological intersection
between helminth infection and allergic reactivity in two
different locales. 
Our data show helminth-mediated protection from airway
inflammatory responses in both OVA and Der p 1 models.
Helminth-driven suppression of effector functions, down-
stream of allergen sensitization, is responsible for protection
from airway inflammation, as down-regulation can be trans-
ferred from infected mice to uninfected, presensitized animals
 
Figure 1.  Airway cell infiltration and tissue pathology are inhibited 
in 
 
H. polygyrus
 
-infected mice. 
 
BALB/c or C57BL/6 mice were sensitized 
to OVA or Der p 1, respectively, by two i.p. injections of 10 
 
 
 
g of allergen 
adsorbed to Alum; 14 and 17 d after the second sensitization, mice were 
given soluble allergen by direct tracheal inoculation. Lavage cells were 
recovered 24 h after final airway challenge (day 31), and histological 
sections made of lung tissues. O:O denotes OVA sensitized (day 0 and 14), 
and challenged (day 28 and 30). D:D denotes Der p 1 sensitized (day 0 and 
14), and challenged (day 28 and 30). Cells were harvested at day 31. 
 
Hp
 
:O:O 
and 
 
Hp
 
:D:D are mice infected with 
 
H. polygyrus
 
 28 d before allergen 
sensitization; D:
 
Hp
 
:D are mice infected 14 d after sensitization, but before 
challenge. (A) Total lavage cell numbers. Data represent means and individual 
data from four experiments (18–20 mice per group) using the same protocol. 
Horizontal bars denote paired experimental groups for which statistical 
significance is displayed in the figure. (B) Eosinophil numbers. All four 
experiments displayed significant reductions in airway eosinophilia in 
infected-allergen challenged animals compared with uninfected allergen 
challenged littermates. (C) Formalin-fixed lung 5-
 
 
 
m sections from naive, 
allergic, and infected-allergic mice stained with hematoxylin and eosin 
(H
 
&
 
E) for nuclear staining of infiltrating cells or stained with AB-PAS for 
mucin-producing goblet cell numbers. (D)
 
 
 
Enumeration of goblet cells, 
stained with AB-PAS in the three groups of mice. Data represent mean 
and SEM of five mice, with a mean score from three representative lung 
sections per mouse. (E) 
 
 
 
-Hexosaminidase in BALF of allergic and infected 
mice. (F) Total cells and eosinophils in mice infected before or after 
allergen sensitization. 
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by mesenteric LN cells (MLNC). Furthermore, protection was
most strongly associated with CD4
 
 
 
CD25
 
 
 
 T cells, which is
consistent with the hypothesis that parasite-induced regulatory
T cells can down-modulate Th2 allergic inflammation.
 
RESULTS
Significantly reduced airway inflammation in 
 
H. polygyrus
 
–
infected animals 
 
We first tested allergic reactivity in the airways of animals
harboring chronic 
 
H. polygyrus
 
 infections, having established
that no changes in airway cell composition or bronchoalveo-
lar lavage fluid (BALF) cytokine secretion in mice occurred
as a result of parasite infection per se (unpublished data).
Mice were sensitized twice with allergen, at day 28 and 42 of
infection, before airway challenge at day 56 and 58. Recov-
ery of airway cellular infiltrates in BALF was performed on
day 59, at which time infection status was also evaluated by
detection of intestinal adult worms.
Infected mice were found to have significantly reduced
airway cellular infiltrates after challenge with OVA (BALB/c,
P 
 
  
 
0.001) or Der p 1 (C57BL/6, P 
 
  
 
0.003) (Fig. 1 A).
Differential counting of cells recovered revealed a profound
reduction of airway eosinophilia (Fig. 1 B, P 
 
  
 
0.0005) and
neutrophilia (Table I). Infected BALB/c mice showed 81.6
and 66.7% decreases in airway eosinophils and neutrophils,
respectively, 24 h after final OVA challenge (Table I). Simi-
larly, C57BL/6 mice had reduced airway eosinophils
(89.0%) and neutrophils (29.0%) 24 h after final challenge
with Der p 1, compared with uninfected controls. Macro-
phage and lymphocyte numbers were also reduced in in-
fected mice after airway challenge (Table I), although the
changes did not reach statistical significance.
 
Reduced tissue pathology in infected mice
 
To determine whether suppressed airway cellular infiltration
represented a more general down-modulation of pathology,
lung histological sections were compared in allergic and in-
fected-allergic animals. Hematoxylin and eosin staining was
used to characterize cellular infiltrates, and Alcian blue–
periodic acid schiff (AB-PAS) to identify mucus-producing
goblet cells in the epithelial border. In addition, mast cell
degranulation was estimated by measuring levels of 
 
 
 
-hex-
osaminidase, in BALF.
In uninfected, allergen-sensitized mice of both strains,
airway challenge leads to a dense peribronchiolar inflamma-
tory infiltrate of lymphocytes, and mononuclear and poly-
morphonuclear cells with epithelial shedding and extended
columnal cells (Fig. 1 C). Furthermore, an accumulation of
mucin-containing goblet cells line the connecting airways,
underpinning the overall increase in mucus production. In
infected mice, however, tissue inflammation after OVA or
Der p 1 challenge was greatly reduced (Fig. 1 C) with signif-
icantly less peribronchial and perivascular cellular infiltration
and mucin staining. Goblet cell numbers showed a substan-
tial reduction in infected mice (Fig. 1 D, P 
 
  
 
0.0005),
whereas the allergen-induced increase in BALF 
 
 
 
–hex-
osaminidase, indicating mast cell mediator release, was also
attenuated in infected mice (Fig. 1 E). 
To distinguish whether infection interfered with allergen
priming or suppressed overt allergic reactions, mice were in-
fected with 
 
H. polygyrus
 
 14 d after the second sensitization
with allergen. As shown in Fig. 1 F, animals infected subse-
quent to sensitization showed a similar suppression of airway
allergy to mice infected at the time of first allergen exposure.
Thus, chronic 
 
H. polygyrus
 
 infection protects mice
against a range of allergic airway inflammatory pathologies,
including fluid and tissue infiltration, mast cell degranula-
tion, and goblet cell proliferation. We selected BAL infiltra-
tion as the keynote parameter to dissect the immunological
mechanisms leading to this broader diminution of pathology.
 
Suppression of local type 2 effector cytokines
 
Local cytokine and chemokine levels were measured in the
BALF, 24 h after the final allergen challenge in vivo. In-
fected mice did not show diminished IL-4 responses, while
the Th1 cell signature cytokine IFN-
 
 
 
 was undetectable in
both infected and uninfected mice (Fig. 2 A). The domi-
nance of Th2 cytokines over Th1 was also observed at
equivalent levels in allergen-challenged thoracic LN (TLN)
cells from both groups (unpublished data). These data indi-
cate that infection does not alter the highly polarized type 2
cytokine environment that is associated with airway allergy.
The type 2 effector cytokine IL-5, and the chemokine eo-
taxin, were both elevated in the BALF of uninfected BALB/c
mice after airway challenge (Fig. 2 B). However, IL-5 and eo-
taxin were significantly diminished by infection (P 
 
 
 
 0.008).
Similar data were obtained for C57BL/6 mice (IL-5 reduced
from 803.6 
 
 
 
 201.6 to 80.5 
 
 
 
 29.4 pg/ml, and eotaxin from
434.4 
 
 
 
 131.1 to 92.1 
 
 
 
 13.7 pg/ml). Reductions in these
two key agents in the mobilization and extravasation of eosin-
ophils provides a mechanistic explanation for the dramatically
reduced airway eosinophilia in infected mice. Although IL-13
levels altered less, they were maximal in uninfected allergic
mice with the most marked goblet cell hyperplasia.
We also examined the regulatory cytokines IL-10 and
TGF-
 
 
 
 (Fig. 2 C). The trend for higher IL-10 in infected
 
Table I.
 
Total cell counts in BALF
 
Cell Type
(
 
 
 
10
 
6
 
 
 
 
 
 SD) Eosinophils Neutrophils Macrophages Lymphocytes
 
BALB/c Naive 0.028 
 
  
 
0.014 0.089 
 
  
 
0.011 0.646 
 
  
 
0.089 0.104 
 
  
 
0.025
O:O 1.054 
 
  
 
0.175 1.265 
 
  
 
0.349 0.909 
 
  
 
0.275 0.236 
 
  
 
0.042
 
Hp
 
:
 
O:O
 
0.224 
 
  
 
0.062 0.421 
 
  
 
0.050 0.410 
 
  
 
0.053 0.144 
 
  
 
0.027
C57BL/6 Naive 0.018 
 
  
 
0.005 0.073 
 
  
 
0.016 0.460 
 
  
 
0.026 0.064 
 
  
 
0.011
D:D 1.639 
 
  
 
0.312 1.591 
 
  
 
0.343 0.394 
 
  
 
0.058 0.339 
 
  
 
0.059
 
Hp
 
:
 
D:D
 
0.239 
 
  
 
0.045 1.129 
 
  
 
0.236 0.371 
 
  
 
0.041 0.188 
 
  
 
0.024
 
O:O denotes OVA sensitized (day 0 and 14) and challenged (day 28 and 30). D:D 
denotes Der p 1 sensitized (day 0 and14) and challenged (day 28 and 30). Cells were 
harvested at day 31. 
 
Hp:O:O
 
 and 
 
Hp:D:D
 
 are mice infected with 
 
H. polygyrus
 
 28 d 
before allergen sensitization. 
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Figure 2.  Bronchio-alveolar lavage cytokine responses. BALF from 
naive, allergic, and infected-allergic mice assayed for the indicated cytokines 
and eotaxin. Data are from individual mice, with arithmetic mean points 
shown in histograms. In cases where responses are similar in BALB/c and 
C57BL/6 mice, data are shown only from the BALB/c response to OVA. 
(A) IFN-  and IL-4, in BALB/c mice; (B) IL-5, IL-13, and eotaxin in BALB/c 
mice; (C) IL-10 and TGF-  in BALB/c and C57BL/6 mice. (D) Allergen-
specific serum IgG1 and IgG2a titers 1 d after the final airway challenge 
in BALB/c mice. (E) Allergen-specific IgE and total IgE levels 1 d after final 
airway challenge in BALB/c mice.  
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animals, only reached statistical significance in C57BL/6
mice (P 
 
 
 
 0.08). In some individual BALB/c mice, the lev-
els of active TGF-
 
 
 
 in BALF were elevated, suggesting that
this mediator may play a major part in immune regulation
during infection. Overall, the two strains appear to differ in
prominence of IL-10 (in C57BL/6) versus TGF-
 
 
 
 (in
BALB/c), and studies are now under way to evaluate the
roles of each cytokine in the two genetic backgrounds for
infection and allergy. 
 
Antibody isotype responses in infection and allergy 
 
Helminth infections can stimulate a type 2 antibody response
(IgG1 and IgE) both to the parasite and to bystander antigens
(43, 44). We therefore measured allergen-specific IgG1 and
IgG2a isotype responses in BALB/c mice to OVA allergen.
It was found that IgG1 increased significantly in infected
mice (Fig. 2 D, P 
 
  
 
0.05), which is consistent with the re-
ported high IL-4 environment (45). Less expectedly, IgG2a
also rose, although without reaching statistical significance.
We next established that allergen-driven IgE responses
were not compromised in helminth-infected mice (Fig. 2 E).
This observation, together with the finding that allergy is
suppressed in animals infected after sensitization (Fig. 1 F),
confirms that Th2 cell priming is not ablated by the parasite
infection. In fact, infected animals had greatly elevated poly-
clonal IgE titers compared with uninfected animals after air-
way challenge. Elevated polyclonal IgE is symptomatic of
most helminth infections, and has been posed as a mechanism
of escape from allergy, out-competing parasite-specific IgE
for binding sites on mast cell IgE receptors (19). We show,
using a transfer experiment (see “Transfer of protection...”),
that this hypothesis is not supported in this model system. 
 
Anti-CD25 antibodies block suppression 
 
Allergic responses can be down-modulated by the action of
T reg cells, through suppressive mediators such as TGF-
 
 
 
(46) or IL-10 (47). Many T reg cell populations constitu-
tively express the IL-2R
 
 
 
 chain, CD25, and such cells can
be depleted in vivo using anti-CD25 (PC61) monoclonal
antibody (48), with the caveat that activated CD25
 
 
 
 effector
cells may also be affected. Thus, enhanced responsiveness af-
ter CD25
 
 
 
 cell depletion is likely to reflect loss of T reg cell
activity, whereas diminished responses may result from ef-
fector cell depletion. In addition, IL-10 is considered to ex-
ert a major influence on airway allergy, and its overexpres-
sion can suppress airway inflammation (36). The action of
IL-10 family cytokines can be ablated in vivo by injection of
antibody to the IL-10R (49).
We administered anti-CD25 antibody to infected and
uninfected OVA–sensitized mice 1 d before airway chal-
lenge (Fig. 3 A), and found that airway infiltration was re-
stored in infected mice (Fig. 3 B). However, recipients of
anti–IL-10R antibody showed unchanged levels of airway
infiltration and eosinophilia (Fig. 3 B). Importantly, antibod-
ies to CD25 or IL-10R in uninfected-allergic mice had no
significant effects on airway infiltrates. These studies suggest
that a cellular population expressing CD25 may be responsi-
ble for the suppression of airway infiltration, but that IL-10
signaling during airway provocation is not responsible for
the observed protection from allergy. 
 
Transfer of protection against allergy with MLNC from 
infected mice
 
To investigate whether a defined cellular population that
was generated during chronic infection is capable of sup-
pressing airway inflammation, we adoptively transferred
MLNC taken 28 d after 
 
H. polygyrus
 
 infection (Fig. 4 A).
MLNC at d 28 were found to express elevated levels of the
Figure 3. Anti-CD25 and anti–IL-10R antibody intervention in 
infected and allergic mice. (A) Protocol for treatment with anti-CD25 and 
anti–IL-10R antibodies. Naive or chronically infected mice were sensitized as 
previously described in “Significantly reduced airway inflammation...”; mice 
received 1 mg of isotype control, PC61 (anti-CD25), or 1B1.3a (anti–IL-10R) 
i.p. 1 d before airway challenge on day 56. Anti–IL-10R was also administered 
on day 58, 1 d before a final airway challenge on day 59. The experiment 
was terminated on day 60. (B) Total cell counts and eosinophil numbers in 
BALB/c mice treated with isotype control, and anti-CD25 or anti–IL-10R 
mAbs. In control Ab-treated animals, both total (P   0.05) and eosinophil 
infiltration (P   0.05) in H. polygyrus–infected mice were significantly 
reduced, using Student’s t test. In PC61 treated mice, uninfected and 
infected groups were not statistically different.  
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Figure 4. Transfer of protective effect with MLNC.
 
 (A) Protocol for 
transfer. All MLNC populations were harvested from donor mice 28 d after 
infection with 
 
H. polygyrus
 
 and transferred to recipients 7 d before airway 
challenge. (B) TGF-  expression in MLNC from naive and infected mice 
assayed by flow cytometry at day 14, 21, and 28 after infection with 
monoclonal anti–TGF- 1. Error bars show the mean   SEM. (C) Expression 
of Foxp3 transcription factor and IL-4, IFN- , and IL-10 by CD25  and 
CD25  MLNC from naive and 28-d-infected mice. For intracellular staining 
of Foxp3 and cytokines, representative individual FACS plots are shown 
against CD25 staining, together with a summary of percentage of positive JEM VOL. 202, November 7, 2005 1205
ARTICLE
T reg cell–associated cytokine TGF-  (Fig. 4 B) as well as
the transcription factor, Foxp3, and the proportion of
CD4 CD25  MLN T cells from infected mice that were
Foxp3  was consistently  85% (Fig. 4 C). Foxp3 expres-
sion was also determined by RT-PCR: CD4  MLNC from
28-d infected mice contained more than fivefold higher lev-
els of Foxp3 mRNA than similar cells from naive animals.
Moreover, within the CD4  T cell population, levels were
maximal in the CD25  cell fraction (0.88 relative to  -actin),
whereas Foxp3 mRNA was below threshold values in the
CD25  population. CD4 CD25  cells contained rela-
tively little IL-4 or IFN-  by cytoplasmic staining. Both
CD25  and CD25  subsets responded to parasite antigen
challenge with IL-10 release, with the CD25  population
making the larger contribution (Fig. 4 C). Day 28 MLNC
were therefore transferred into the tail veins of uninfected,
allergen-sensitized recipient mice. After a further 7 d, recip-
ient mice were given the first of two airway challenges, and
airway responses were measured 1 d after the final challenge
(Fig. 4 A).
In the first instance, 5   107 MLNC from infected or na-
ive donor mice were transferred i.v. into allergen-sensitized
BALB/c or C57BL/6 mice. MLNC from infected donors
could transfer the protective effect to uninfected sensitized
recipients, but naive MLNC induced no marked changes in
response. Substantial declines in eosinophil infiltration were
observed in mice receiving infected MLNC, compared with
those receiving naive MLNC, after allergen challenge. Naive
MLNC had no effect on total airway infiltrates or eosino-
philia after allergen challenge. Suppression could be observed
with as few as 107 MLNC from chronically infected donors
(data not shown). Transfer of MLNC from chronically in-
fected C57BL/6 mice into Der p 1–sensitized recipients ob-
tained similar results, with significantly reduced total (Fig. 4
D, P   0.008) and eosinophil (P   0.02) infiltrates. Der p
1-sensitized C57BL/6 mice showed alleviation of airway in-
filtration when given MLNC from infected donors, whether
or not recipient animals were given 100  g H. polygyrus anti-
gen 1 d later (unpublished data). From these experiments,
MLNC were shown not to require antigen reexposure to
transfer the protective effect to allergen-sensitized recipients.
Transfer of protection with CD4  T cells
CD4  and CD4  cells were isolated from MLNC of d 28
infected animals and transferred into uninfected sensitized
recipients. OVA-sensitized BALB/c mice displayed a signifi-
cant reduction in total airway infiltrates after CD4  cell
transfer and airway challenge (Fig. 4 D). Suppression of air-
way eosinophilia was observed after the transfer of CD4 
(P   0.0001) or CD4  (P   0.025) cells, respectively. These
results from the BALB/c model demonstrate that CD4  T
reg cells, engendered during a chronic H. polygyrus infection,
can transfer protection against allergy to an allergen-sensi-
tized animal if given before the time of airway challenge.
The regulatory activity may not, however, be limited to
a single cellular population. In C57BL/6 mice sensitized to
Der p1, transfer of either CD4  or CD4  cells resulted in re-
duced airway infiltrates and eosinophilia, and in some cases,
(Fig. 4 E) the CD4  population showed greater potency.
Because the two regulatory populations evident in infected
C57BL/6 mice develop in the absence of allergen sensitiza-
cells taken from groups of five mice. The total number of CD25  MLNC 
expressing Foxp3 in naive and infected mice is presented, together with 
the frequency of these cells within the whole CD4  T cell population and 
the proportion of CD25  cells that express Foxp3. Antigen-specific cytokine 
release was measured by ELISA from supernatants of 72-h cultured CD25-
depleted or -enriched MLNC stimulated with medium or antigen extract 
from H. polygyrus adult parasites. (D) Total cell counts and eosinophil numbers 
in mice receiving 5   107 MLNC from naive or infected donors. In the 
experiment with BALB/c mice, 100  g of soluble adult parasite antigen 
was given 1 d after administration of either naive or infected donor cells. 
(E) Total cell counts and eosinophil numbers in mice receiving 4   106 
CD4  or CD4  MLNC from infected donors. Cell fractions were 92.4% 
(CD4 ) and 94.9% (CD4 ) pure for BALB/c and 93.1% (CD4 ) and 98.1% 
(CD4 ) pure for C57BL/6. Group sizes were 8–10 for BALB/c and 15 for 
C57BL/6 mice. (F) Total IgE and allergen-specific IgE, measured in IgG-depleted 
serum, measured in BALB/c mice receiving 4   106 CD4  or CD4  MLNC 
from infected donors. Serum samples were collected from blood 1 d after 
final airway challenge. (E) Total cell counts and eosinophil numbers in 
mice receiving 4   106 CD4  or CD4  MLNC from infected donors. Cell 
fractions were 92.4% (CD4 ) and 94.9% (CD4 ) pure for BALB/c and 
93.1% (CD4 ) and 98.1% (CD4 ) pure for C57BL/6. Group sizes were 8–10 
for BALB/c and 15 for C57BL/6 mice. (F) Total IgE and allergen-specific IgE, 
measured in IgG- depleted serum, measured in BALB/c mice receiving 
4   106 CD4  or CD4  MLNC from infected donors. Serum samples were 
collected from blood 1 d after final airway challenge.HELMINTH DOWN-REGULATION OF ALLERGIC INFLAMMATION | Wilson et al. 1206
tion, it is likely that the prominence of CD4  activity in this
strain relative to BALB/c reflects a genetic difference rather
than the choice of allergen used in the two systems.
Unaltered IgE responses accompany suppressed allergy
The transfer of CD4  cells from infected animals to un-
infected, sensitized mice (Fig. 4 F) did not alter total or al-
lergen-specific IgE levels in recipient mice. This finding
supports the thesis that a cellular population that was en-
gendered during helminth infection is the major contributor
to overall protection from allergic reactivity, and although
increased levels of total IgE may play a role in diluting aller-
gen-specific IgE and/or occupy Fc R on mast cells and ba-
sophils, it is not the major component of the protective
effect observed.
IL-10 /  MLNC transfer protection 
CD4  and CD4  cells were isolated from MLN of chroni-
cally infected IL-10–/– mice and transferred into uninfected
sensitized wild-type recipients. As shown in Fig. 5, the lack
of IL-10 did not compromise the ability of transferred CD4 
cells to suppress allergic reactions. Recipients of IL-10–/–
CD4  cells showed significantly reduced airway infiltration
and eosinophilia (P   0.05) compared with animals receiving
wild-type CD4  cells. Transfer of CD4  cells from either IL-
10–/– or wild type showed a diminution of allergic outcome
that narrowly failed to show statistical significance. Hence,
IL-10 is not an essential component of the pathway by which
helminth-induced cells can suppress host allergic reactivity.
CD4 CD25  T cells transfer protection
To test directly whether infection induces CD25  T reg
cells, day 28 MLNC from infected mice were separated into
CD4 CD25 – and CD4 CD25 –enriched populations,
and transferred into allergen-sensitized recipients 7 d before
airway challenge (Fig. 4 A). In both strains of mice, the most
puissant reduction of airway inflammation occurred with the
transfer of CD4 CD25  cells. CD4 CD25  cell transfer re-
duced not only total airway infiltrates (Fig. 6) but also airway
eosinophilia (BALB/c, P   0.02; C57BL/6, P   0.02), and
goblet cell proliferation (BALB/c, P   0.05). Evidence was
also found that the CD4 CD25  subset also contributes to
an abatement of allergic reactivity, but not as consistently as
CD4 CD25  cells. Overall, our data suggest that the
CD4 CD25  phenotype T cell population, at least, can me-
diate suppression of airway allergy in both strains of mice.
Migration of donor MLNC to the lungs and TLNs 
To investigate whether transferred MLNC are capable of re-
locating to airway-associated tissues in recipient sensitized
mice, we followed the fate of transferred cells bearing the
Ly5.1 allotypic marker, which permits donor cell identifica-
tion after transfer into C57BL/6 (Ly5.2) mice. CD4  and
CD4  Ly5.1 MLNC transferred i.v. into sensitized C57BL/6
mice 7 d before airway challenge could be found in the lo-
cal draining LNs, composing 0.42   0.18% and 0.39  
0.07% of the CD4  and CD4  population, respectively (Fig.
7). Similarly, 0.18   0.10% and 0.30   0.14% of lung
CD4  and CD4  cells were Ly5.1 . These data suggest that
donor cells from chronically infected mice migrate to sites of
inflammation, either to directly suppress host responses, or to
conscript resident cells into a regulatory phenotype.
DISCUSSION
Allergies are Th2 cytokine–mediated pathologies, involving
IL-4–, IL-5– and IL-13–dependent amplification of innate
effector cell populations acting together with antibodies and
inflammatory mediators (50). As Th1 and Th2 cell responses
are mutually antagonistic, it has been argued that declining
microbial stimulation of Th1 cell responses in the developed
world has led to over-vigorous allergic Th2 cell reactions
(51). However, allergen-specific Th1 cells can in fact exacer-
bate airway inflammation (52). Moreover, epidemiological
reports increasingly link Th2 cell–inducing helminth parasite
infections with reduced allergic disease in humans (53),
whereas nematode-infected mice display attenuated allergic
responses (28, 54, 55). Current theories postulate that patho-
gen-induced T reg cells control both Th1 and Th2 effector
populations (2, 3, 11, 16, 27, 53). The possibility that T reg
cells inhibit allergic disease has received growing support
from both animal (13, 56) and human (14, 15, 57) studies.
Figure 5. Suppression of allergy by MLNC transfer is intact in IL-10–
deficient donors. Total cell counts and eosinophil numbers in Der p 1-sen-
sitized WT C57BL/6 mice receiving 4   106 CD4  or CD4  MLNC from WT or 
IL-10–deficient infected donors. At day 7 and 9 after cell transfer, airway 
challenges were given, and BALF harvested 24 h after final challenge.JEM VOL. 202, November 7, 2005 1207
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We now provide direct experimental evidence to sup-
port the hypothesis that helminth infection down-regulates
allergic reactions through the action of regulatory T cells
rather than by altering the Th1–Th2 balance. To do this, we
selected the murine intestinal nematode H. polygyrus as a
model of helminthiasis (28, 58), because it follows a purely
enteric infective cycle and establishment; has the ability to
establish stable, chronic infections; and evokes a Th2 cell–
dominated immune response similar to that observed in gen-
eral with gastrointestinal nematodes. We chose an allergic
Figure 6 (continued on next page)
Figure 6. Transfer of protective effect with CD4 CD25  MLNC. 
(A) Total cell, eosinophil, and goblet cell numbers in mice receiving 3   
105 CD4 CD25  or CD4 CD25  MLNC from infected donors. (B) Purity 
of CD4 CD25  and CD4 CD25  populations assayed by flow cytome-
try. C57BL/6 MLNC fractions, which were 87.6% (CD4 CD25 ) and 
88.1% (CD4 CD25 ) pure, are shown. Enriched cell fractions from 
BALB/c were 60.6% (CD4 CD25 ) and 79.6% (CD4 CD25 ) pure. HELMINTH DOWN-REGULATION OF ALLERGIC INFLAMMATION | Wilson et al. 1208
airway inflammation model that permited us to observe
modifications in cellular recruitment, cytokine and chemo-
kine expression, and tissue pathology. We also opted to
study two allergens in parallel, which induce airway inflam-
mation in different strains of mice: the environmental house
dust mite allergen Der p 1, in C57BL/6 mice; and the ex-
perimental allergen, OVA in BALB/c mice.
Mice carrying an established helminth infection are
shown here to be less prone to allergic airway inflammation,
whether measured by the inflammatory infiltrate in BALF or
by peribronchial and perivascular inflammation. Our results
extend earlier work with H. polygyrus that demonstrate a re-
duced allergy to food antigens in mice infected with this par-
asite (28). More broadly, these findings can be translated to
the human situation, in which individuals carrying active
helminth infections appear, in epidemiological studies, to be
less responsive to allergen provocation than coresidents free
of infection (17, 20, 21, 59, 60). 
To address the mechanisms involved in helminth-induced
suppression, we first established that the Th2-driving cy-
tokine IL-4 was unaffected, as was the overall Th1–Th2
balance. However, the Th2 effector cytokines IL-5 and IL-
13 were diminished, as was the inflammatory phase within
the lung. Thus, Th2 cell–associated pathological reactions
were suppressed within the context of a Th2 cell–inducing
helminth infection. The fact that Th2 cell priming occurs
normally is shown by the similar allergen-specific IgE re-
sponses in infected and uninfected mice, and the ability of
the suppressive mechanism to target the effector phase is fur-
ther demonstrated by the impact of infection on a previously
sensitized allergy-prone host (Fig. 1 F). The hypothesis that
T reg cell activity may be responsible for this phenomenon
was supported by our finding that anti-CD25 antibody treat-
ment reversed suppression. However, allergic inflammation
was not restored by the administration of anti–IL-10R anti-
body, indicating that T reg cell activity in this setting is not
IL-10 dependent. 
We then used the adoptive transfer system of MLNC
from infected mice into sensitized, but uninfected, hosts to
demonstrate that down-regulation is mediated by T cells, pri-
marily those with the CD4 CD25  phenotype associated
with T reg cells (61, 62). Several distinct regulatory pheno-
types of T reg cell cells have been proposed, including “Th3”
cells, primarily acting through TGF- , which are most
closely associated with the gut mucosal environment, and
“Tr1” cells, which are capable of suppressing airway allergy
through the action of IL-10 (13, 56). Interestingly, the H. po-
lygyrus-elicited T reg cells are generated in the Th3 environ-
ment, but manifest their function in the Tr1 environment. 
Although the CD4 CD25  subset was the most potent
at suppressing allergic inflammation, some activity could also
be observed in the CD4  population, particularly in the
C57BL/6 system. Although this may represent a CD8  reg-
ulatory T cell (63), we also have evidence that CD19  B cell
populations are able, on transfer, to exert a dampening effect
on immunopathology. Perhaps, in the down-regulatory mi-
lieu of a chronic infection, additional non–T reg cell types
are recruited to curtail pathology more completely.
The cells transferred from infected mice express elevated
levels of IL-10 and TGF- , the two principal T reg cell–asso-
ciated down-regulatory cytokines, and contain a significantly
higher number of CD4 CD25 Foxp3  cells. However, de-
spite the prominence of IL-10 production by H. polygyrus-
exposed T cells, their ability to suppress airway allergy is not
mediated by IL-10, as MLNC from infected IL-10–/– mice
can mediate suppression, which is consistent with the failure
of anti–IL-10R antibodies to reverse suppression in infected
animals. In contrast, TGF-  remains a strong candidate for
immune suppression by T reg cells from helminth-infected
mice, particularly as this cytokine is known to alleviate exper-
imental airway allergy (37) and has the capacity to instruct
peripheral T cells to develop regulatory capacity (46, 64).
CD4 CD25  T cells are generally associated with self-
reactive regulatory cells that prevent autoimmune reactivities
(61, 62). Hence, the expansion of CD4 CD25  cell–medi-
ated regulatory activity in infection raises the issue of the ori-
gin and antigen specificity of these cells (65, 66). Are there
preexisting “natural” T reg phenotype cells that expand in re-
sponse to infection, or can parasite antigen-specific regulatory
cells arise from naive Th0 precursors? In this respect, the fact
that transfer of suppression did not require renewed antigen
stimulation was striking. One possibility is that the T reg cell
population is self-reactive rather than parasite specific, and is
restimulated by ligands in the recipient host. However, it has
been shown that T reg cells specific for exogenous antigen
(alloantigen or HGG), reactivated in a donor immediately
before transfer, suppressed bystander allograft responses in a
Figure 6 (continued from previous page)
(C) AB-PAS staining of formalin-fixed lung tissue, staining mucin-
producing goblet cells, in BALB/c mice receiving 3   105 CD4 CD25  
or CD4 CD25  MLNC from infected donors.JEM VOL. 202, November 7, 2005 1209
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recipient without the need for antigen restimulation in the
new host (67). Thus, it is possible that chronic parasite infec-
tion maintains a high level of activation in T reg cells, suffi-
cient for their function in our short-term experiments. As
with other instances of T reg cell responses to pathogens (66),
these issues are currently under active investigation.
The transfer model also allows us to exclude changes in an-
tibody production as a major mechanism for abatement of al-
lergy. For example, the production of allergen-specific-IgE is
comparable in mice who have received naive or infected
MLNC, which show respectively normal and suppressed aller-
gic reactions. There is also no rise in polyclonal IgE in recipients
of infected CD4  T cells, arguing that changes in either abso-
lute allergen-specific IgE, or in the ratio of nonspecific to spe-
cific IgE, are not responsible for the diminution of allergic re-
sponses in infected animals. A similar conclusion was drawn
from measurements of specific and total IgE in atopic and non-
atopic humans harboring chronic schistosome infections (21). 
A final intriguing question is why helminth parasites such
as H. polygyrus and Schistosoma mansoni (68) induce T reg cells.
As argued elsewhere (27), parasites that can exploit host
down-regulatory networks are likely to gain advantage in the
battle for long-term survival in the host. Much of the pathol-
ogy encountered in helminth infection is immune mediated
(69), and a dampening of responsiveness would not necessar-
ily compromise the host. However, the immune system may
have evolved to operate optimally in the regulated environ-
ment of infection, and in our more hygienic environment,
we are prone to overzealous reactions to innocuous targets,
generating the rapidly increasing levels of allergy and autoim-
munity being experienced in the developed world. 
MATERIALS AND METHODS
Animals.  Female BALB/c, C57BL/6, and C57BL/6-Ly5.1 mice, 6–8 wk
old, were housed in individually ventilated cages licensed under UK Home
Office guidelines. At least five mice were used per experimental group. IL-
10–deficient mice were a gift from S. Anderton (University of Edinburgh,
Edinburgh, UK).
Parasites.  Mice were infected with 200 H. polygyrus L3 larvae (provided
in the first instance by J. Behnke, The University of Nottingham, Notting-
ham, UK) using a gavage tube. Infections were verified by detection of eggs
in fecal samples. 
Antigens and allergens. For H. polygyrus antigen, a PBS homogenate of
adult worms was centrifuged (13,000 g for 10 min), and the supernatant was
Figure 7. Tracking of donor lymphocytes in recipient mice. 4   106 
CD4  or CD4  MLNC from infected mice were transferred i.v. into C57BL/6 
(Ly5.2) recipients, 7 d before airway challenge. After the second airway 
challenge, lungs and thoracic lymph node (TLN) cells were recovered and 
stained for Ly5.1 and CD4 expression. Error bars show the mean   SEM.HELMINTH DOWN-REGULATION OF ALLERGIC INFLAMMATION | Wilson et al. 1210
passed through a 0.2- m filter (Millipore). Der p 1, was affinity purified
from spent mite medium using 4C1 mAb as previously published (70).
Grade V OVA (A5503) was purchased from Sigma-Aldrich.
Allergen-induced airway inflammation. Mice were sensitized i.p. with
10  g OVA (BALB/c) or Der p 1 (C57BL/6) adsorbed to 9% potassium
alum (Sigma A7167), and boosted with the same antigen 14 d later. On day
28 and 31, mice were challenged with 10  g OVA or Der p 1 in PBS by the
intratracheal route. Mice were killed 24 h after final airway challenge to as-
sess airway inflammation. For histopathology, formalin-fixed lungs were em-
bedded in paraffin and sectioned. Hematoxylin and eosin stained sections
were analyzed for airway inflammation and pathological changes. Mucus-
containing goblet cells were stained with AB-PAS, and the histological mu-
cus index was quantified for goblet cell hyperplasia (71).
BALF cell counts. At 24 h after final challenge, mice were terminally
anesthetized, the tracheas were cannulated, and internal airspaces were lav-
aged with 500  l PBS, followed by two 350- l washes. Fluids were centri-
fuged at 1,200 g, and pellets recovered for cellular analysis. Initial 500- l
BALF samples were stored at  80 C for biochemical analyses. Cytospins
were prepared by spinning 5   105 cells onto poly-L-lysine–coated slides
(BDH) followed by Diff Quick (Boehringer) staining. Differential cell
counts were performed on a minimum of 200 cells at magnification of 100.
Allergen-specific antibodies and total IgE. Allergen-specific responses
were determined by ELISA. Multisorp (Nunc) plates were coated with 4  g/
ml OVA or Der p 1 in 0.06 M of carbonate buffer, overnight at 4 C. Plates
were blocked with 5% BSA (fraction V; GIBCO BRL) for 2 h at 37 C. Sera
were diluted in TBS, 0.05% Tween (TBS-T) and added to wells overnight at
4 C. Allergen-specific IgG isotypes were detected with HRP-conjugated goat
anti–mouse IgG1 (Southern Biotechnology Associates, Inc.) and anti-IgG2a
and ABTS peroxidase substrate (KPL). For allergen-specific IgE assays, protein
G–Sepharose beads were used to remove IgG from sera; biotinylated anti–
mouse IgE (BD Biosciences), ExtrAvidin–alkaline phosphatase conjugate
(Sigma-Aldrich) and pNPP Substrate (Sigma-Aldrich) were then used. Total
IgE was measured with anti–mouse IgE capture (BD Biosciences) and biotin-
ylated anti–mouse IgE detection, using a monoclonal IgE standard curve.
Cytokines and chemokines. Cytokines were measured by ELISA ac-
cording to suppliers’ guidelines. Capture antibodies for IL-4 (11B11, 4  g/
ml), IL-5 (2  g/ml), IL-10 (4  g/ml) and IFN-  (R46A2, 3  g/ml) were
produced in-house or purchased from BD Biosciences. Capture antibodies
for IL-13 (2  g/ml) and eotaxin (0.4  g/ml) were obtained from R&D Sys-
tems. Biotinylated detection antibodies were purchased from BD Biosciences
(5  g/ml IL-4, 2  g/ml IL-5, 2  g/ml IL-10, and 0.5  g/ml IFN- ) or
R&D Systems (0.1  g/ml IL-13 and 0.4  g/ml eotaxin. TGF-  was mea-
sured with transfected mink lung epithelial cells expressing luciferase under
the plasminogen activator inhibitor 1 promoter (72). To assay  -hexosamini-
dase activity, samples were incubated with 80  l of substrate solution (1.3
mg/ml  p-nitrophenyl- -D-2-acetamido-2-eoxyglucopyranozide [Sigma-
Aldrich] in 0.1 M citrate, pH 4.5). The reaction was stopped by the addition
of 200  l of 0.2 M glycine, pH 10.7, and ODs were read at 405 nm.
Antibodies to CD25 and IL-10R. Anti-CD25 mAb was PC61 rat anti–
mouse IL-2R  monoclonal, produced in-house from cells provided by F.
Powrie (University of Oxford, Oxford, UK), and grown in serum-free media
in a cell growth bag (Bio-Vectra). Antibody was purified on protein G–seph-
arose, dialyzed against PBS, and given i.p. at 10 mg/ml. Rat anti–mouse
CD210 (IL-10R) antibody was IgG1 monoclonal 1B1.3a (BD Biosciences).
Adoptive cell transfer. MLNs were removed from mice infected 28 d
earlier with H. polygyrus. Single-cell suspensions in RPMI–0.5% normal
mouse serum were made using a cell strainer. For whole MLNC transfers,
1–5   107 cells were injected i.v. in PBS. Mice received MLNC 7 d after a
second allergen sensitization, which was 7 d before airway challenge. 
CD4  and CD25  cell enrichment. For CD4  cell purification, cell
suspensions were incubated with CD4 (L3T4) microbeads (Miltenyi Bio-
tech) and separated on MACS LS columns with preseparation filters; 4  
106 CD4  or CD4  cells were injected i.v. into recipient mice. For
CD4 CD25  cell enrichment, CD4  cells were first negatively isolated us-
ing streptavidin microbeads (Miltenyi Biotec) and biotinylated anti-CD11b
(BD Biosciences), anti-CD8  (BD Biosciences), anti-MHC class II
(M5114) and anti-Ig  (187.1). Antibody-bound beads and cell solutions
were separated on MACS LS columns. CD25  cells were then positively
selected with biotinylated anti-CD25 (BD Biosciences) and streptavidin mi-
crobeads. Uninfected, allergen-sensitized mice received 3   105
CD4 CD25  or CD4 CD25  cells from infected donors 7 d before the
first airway challenge. 
Flow cytometry. Antibodies were diluted in PBS, 0.5% BSA (Sigma-
Aldrich), 0.05% sodium azide. Cells were stained for 20 min at 4 C. For de-
tection of CD4 CD25  and CD4 CD25  cells, rat anti–mouse CD4 (L3T4,
clone RM4-5, IgG2a) and anti-CD25 (clone PC61, IgG1; CALTAG) mAbs
were used. For detection of donor C57BL/6-Ly5.1 (CD45.1) cells in recipi-
ent mice, anti-CD45.1 (clone A20, mouse IgG2a) was used. For staining in-
tracellular cytokines, cells were permeabilized in cytofix/cytoperm, washed
in perm/wash buffer (BD Biosciences), and stained with anti–mouse IL-4
(11B11), IFN-  (XMG1,2), or IL-10 (JES5-16E3) for 30 min. For Foxp3
staining, a kit from eBioscience using mAb FKJ-16s was used according to
the manufacturer’s instructions. Surface bound TGF-  was detected using
rat anti–mouse TGF- 1 (A75-3, IgG2a). The expression of surface markers
and intracellular IL-10 was analyzed on a FACSCalibur flow cytometer using
FlowJo software (Tree Star). All fluorochrome-labeled antibodies were ob-
tained from BD Biosciences, unless otherwise stated.
Statistics. Student’s t test was used for all statistical comparisons; p-values
 0.05 were considered significant. 
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